One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P(®)/Humate P(®) treatment in von Willebrand disease patients

INTRODUCTION: Many patients with von Willebrand disease (VWD) are treated on demand with von Willebrand factor and factor VIII (FVIII) containing concentrates present with VWF and/or FVIII plasma levels outside set target levels. This carries a risk for bleeding and potentially for thrombosis. Devel...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Thromb Haemost
Main Authors: de Jager, Nico C. B., Bukkems, Laura H., Heijdra, Jessica M., Hazendonk, Carolien H. C. A. M., Fijnvandraat, Karin, Meijer, Karina, Eikenboom, Jeroen, Laros ‐ van Gorkom, Britta A. P., Leebeek, Frank W. G., Cnossen, Marjon H., Mathôt, Ron A. A., Collins, P. W.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
HAEMOSTASIS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028136/
https://ncbi.nlm.nih.gov/pubmed/31557387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14652
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki